Analysis of the inhibitory mechanism of d-allose on MOLT-4F leukemia cell proliferation

Journal of Bioscience and Bioengineering

Volumn 107, Issue 5, 2009, Pages 562-568

  Hirata, Yuko ^a   Saito, Madoka ^b   Tsukamoto, Ikuko ^a   Yamaguchi, Fuminori ^a   Sui, Li ^a   Kamitori, Kazuyo ^a   Dong, Youyi ^a   Uehara, Eisuke ^a   Konishi, Ryoji ^a   Janjua, Najma ^c   Tokuda, Masaaki ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

^c KAGAWA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

Author keywords

Anticancer; d allose; Leukemia cell line; Rare sugar; TXNIP

Indexed keywords

ANTICANCER; D-ALLOSE; LEUKEMIA CELL LINE; RARE SUGAR; TXNIP;

CELL DEATH; CELL PROLIFERATION; GLUCOSE; SUGAR (SUCROSE);

CELL CULTURE;

ALLOSE; THIOREDOXIN INTERACTING PROTEIN;

APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DAUDI CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROTEIN EXPRESSION; T CELL LEUKEMIA;

CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; HUMANS; LEUKEMIA;

EID: 64749115378     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2008.12.021     Document Type: Article

References (24)

1. McDonald E.J. A new synthesis of d-psicose (d-ribo-hexulose). Carbohydr. Res. 5 (1967) 106-108
2. Doner L.W. Isomerization of d-fructose by base: liquid-chromatographic evaluation and isolation of d-psicose. Carbohydr. Res. 70 (1979) 209-216
3. Izumori K. Bioproduction strategies for rare hexose sugars. Naturwissenschaften 89 (2002) 120-124
4. Hossain M.A., Wakabayashi H., Goda F., Kobayashi T., Maeba T., and Maeta H. Effect of the immunosuppressants FK506 and d-allose on allogenic orthotopic liver transplantation in rats. Transplant. Proc. 32 (2000) 2021-2023
5. Hossain M.A., Izuishi K., Tokuda M., Izumori K., and Maeta H. d-Allose has a strong suppressive effect against ischemia/reperfusion injury: a comparative study with allopurinol and superoxide dismutase. J. Hepatobiliary Panctreat. Surg. 11 (2004) 181-189
6. Murata A., Sekiya K., Watanabe Y., Yamaguchi F., Hatano N., Izumori K., and Tokuda M. A novel effect of d-allose on production of reactive oxygen species from neutrophils. J. Biosci. Bioeng. 96 (2003) 89-91
7. Hirooka K., Miyamoto O., Jinming P., Du Y., Itano T., Baba T., Tokuda M., and Shiraga F. Neuroprotective effects of d-allose against retinal ischemia-reperfusion injury. Invest. Ophthalmol. Vis. Sci. 4 (2006) 1653-1657
8. Sui L., Dong Y., Watanabe Y., Yamaguchi F., Hatano N., Tsukamoto I., Izumori K., and Tokuda M. The inhibitory effect and possible mechanisms of d-allose on cancer cell proliferation. Int. J. Oncol. 27 (2005) 907-912
9. kip1. Int. J. Oncol. 32 (2008) 377-385
10. Sui L., Dong Y., Watanabe Y., Yamaguchi F., Hatano N., Izumori K., and Tokuda M. Growth inhibitory effect of d-allose on human ovarian carcinoma cells in vitro. Anticancer Res. 25 (2005) 2639-2644
11. Ministry of Internal Affairs and Communications (ed.): Japan Statistical Yearbook 2008, p. 686-687. Ministry of Internal Affairs and Communications, Japan (2007).
12. Parikh H., Carlsson E., Chutkow W.A., Johansson L.E., Strgaard H., Poulsen P., Saxena R., Ladd C., Schulze P.C., Mazzin M.J., et al. TXNIP regulates peripheral glucose metabolism in humans. PLoS Med. 4 (2007) 0868-0879
13. Chung J.W., Jeon J.H., Yoon S.R., and Choi I. Vitamin D3 upregulated protein (VDUP1) is a regulator for redox signaling and stress-mediated diseases. J. Dermatol. 33 (2006) 662-669
14. 3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 22 (2003) 4035-4046
15. Tomoda K., Kubota Y., Arata Y., Mori S., Maeda M., Tanaka T., Yoshida M., Yoneda-Kato N., and Kato J. The cytoplasmic shuttling and subsequent degradation of p27kip1 mediated by jab1/CSN5 and the COP9 signalosome complex. J. Biol. Chem. 277 (2002) 2302-2310
16. Chiarle R., Budel L.M., Skolnik J., Frizzera G., Chilosi M., Corato A., Pizzolo G., Magidson J., Montagnoli A., Pagano M., et al. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood 95 (2000) 619-626
17. kip1 is instigated by jab1. Nature 398 (1999) 160-165
18. Claret F.X., Hibi M., Dhut S., Toda T., and Karin M. A new group of conserved co-activators that increase the specificity of AP-1 transcription factors. Nature 383 (1999) 453-457
19. Jeon J.H., Lee K.N., Hwang C.Y., Kwon K.S., You K.H., and Choi I. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. Cancer Res. 65 (2005) 4485-4489
20. Roseman J.M., Miller E., Seltzer M.H., Wolfe D., and Rosato F.E. The effect of l-fucose on rat mammary tumor growth. II. in vitro studies. J. Surg. Oncol. 3 (1971) 79-88
21. Wolfe D.E., Roseman J.M., Seltzer M.H., Miller E.E., and Rosato F.E. Further observations of l-fucose as a specific inhibitor of rat mammary carcinoma in tissue culture. Growth 34 (1970) 379-384
22. Ikarashi M., Takahashi Y., Ishii Y., Nagata T., Asai S., and Ishikawa K. Vitamin D3 up-regulated protein 1 (VDUP1) expression in gastrointestinal cancer and its relation to stage of disease. Anticancer Res. 22 (2002) 4045-4048
23. Escrich E., Moral R., Garcia G., Costa I., Sanchez J.A., and Solanas M. Identification of novel differentially expressed genes by the effect of a high-fat n - 6 diet in experimental breast cancer. Mol. Carcinog. 40 (2004) 73-78
24. Hui S.T.Y., Andres A.M., Miller A.K., Spann N.J., Potter D.W., Post N.M., Chen A.Z., Sachithanantham S., Jung D.Y., Kim J.K., and Davis R.A. Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 3921-3926